Brief: Titan Pharmaceuticals Reports Q2 Loss Per Share $0.05
14/08/2020 14:01
Aug 14 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS REPORTS SECOND QUARTER 2020
FINANCIAL
RESULTS
* Q2 LOSS PER SHARE $0.05
* Q2 REVENUE $1.3 MILLION
* TITAN PHARMA - AS OF JUNE 30, HAD CASH & CASH EQUIVALENTS
OF
ABOUT $5.5 MILLION, WHICH CO BELIEVES ARE SUFFICIENT TO FUND
PLANNED OPERATIONS THROUGH Q3
Source text for Eikon: ID:nPnbCW14Ja
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.